Smart Inhalers Market Share Report - Global Forecast 2027

Smart Inhalers Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product (Nebulizers and Inhalers); Disorder {Chronic Obstructive Pulmonary Disease (COPD) and Asthma}; End User (Home-Care Settings and Hospitals & Clinics), and Geography

Publication Month : Jun 2019

  • Report Code : TIPRE00004568
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 144
Inquire Before Buy

PRICING

$4550

$2730

[Research Report] The global smart inhalers market is expected to reach US$ 8,033.21 Mn by 2027 from US$ 1,094.26 Mn in 2018. The market is estimated to grow with a CAGR of 25.5% from 2018-2027. The report highlights the trends and drivers prevailing in the smart inhalers market.

 

Analyst Perspective

Smart inhalers use Bluetooth technology to identify the use of inhaler as well as remind patients to take their medication and gather data to help guide care. Other than the management of respiratory diseases, the device also sends an alert on smartphones when a patient enters a high pollen or highly polluted area, which helps a patient decide whether to avoid the environment. Driving factor such as increasing levels of air pollution as well as rise in the smoking habits, rising prevalence of asthma and COPD across the globe and growing geriatric population are expected to boost the smart inhalers market growth over the years. However, limited knowledge regarding the use of smart inhalers and the risks associated with cyber threats are likely to have a negative impact on the smart inhalers market growth in the coming years.

Market Overview

Smart inhalers are advanced form of inhalers that are digitally connected to apps on phone or tablet, which helps the physicians to manage patient’s medical condition more effectively. Smart inhalers have sensors, enabling the patients to automatically track how often the inhaler is being used by the patient, hence avoiding the chances of any human errors.

The segmentation scope of the smart inhalers market includes product, disorder, end user, and geography. The market for smart inhalers is analyzed on basis of five strategic regions across the globe such as North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. The report offers insights and in-depth analysis of the smart inhalers market emphasizing on various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the globe.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Smart Inhalers Market: Strategic Insights

smart-inhalers-market
Market Size Value inUS$ 1,094.26 Million in 2018
Market Size Value byUS$ 8,033.21 Million by 2027
Growth rateCAGR of 25.5% from 2018 to 2027
Forecast Period2018-2027
Base Year2018
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Market Trend

Increasing Acceptance of Mobile Health Technology Likely to be a Prevalent Trend Within The Smart Inhalers Market Growth

The current scenario of the mobile health platforms is increasing day by day. The increasing adoption of universally advanced technology is expected to propel the smart inhalers market growth in the forecast period. For 2017, the number of smartphone users in Canada was estimated to reach 24.02 million. The increasing penetration of smartphones and growing wireless network technology provides improved digital healthcare system with novel opportunities to address more challenges that associated with accessibility, quality, effectiveness, efficiency and cost of healthcare. Additionally, the use of smartphones among common populace with respect to healthcare applications is also on the verge of increase. For instance, according to a report published in JMIR Mhealth Uhealth Journal in October 2016, 58.23% of mobile phone users participated in the survey in the US had downloaded and used healthcare apps and used them for various purposes. This will lead to an increasing adoption of the mobile health technology in the digital health community and likely to be a prevalent trend within the smart inhalers market.

Segment Analysis

Global smart inhalers market, based on disorder was segmented into asthma and chronic obstructive pulmonary disease. In 2018, the asthma segment likely to hold significant smart inhalers market share. In addition, segment is also expected to grow at the fastest rate during the coming years owing to rising prevalence of asthma among the developed as well as developing economies. Asthma is a chronic disease of the airways that transport air to and from the lungs. In this condition, the airways narrow and swell producing extra mucus, which leads to difficulty in breathing and triggers coughing, wheezing and shortness of breath. Complete cure for asthma isn’t available, however its symptoms can be controlled. The symptoms of asthma vary from person to person, ranging from mild to severe. Some of the common symptoms of asthma include, shortness of breath, chest pain or tightness, extreme coughing or whistling or wheezing sounds.

If the intensity of the symptoms is much severe due to a set of inflammatory events in the respiratory system is known as an asthma attack. Worldwide, around 250,000 people die every year as a result of asthma. At present around 235 million people currently suffer from asthma. In addition, according to the latest WHO estimates, released in December 2016, there were approximately 383 000 deaths due to asthma in 2015. The rising prevalence of the disorder as well as the increasing mortality rate of asthma is anticipated to fuel the demand for the smart inhalers market in the segment during the forecast period.

Regional Analysis

Global Smart inhalers market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. During 2018, the region of North America held a maximum share in the smart inhalers market, generating a revenue of US$ 503.91 Mn, which is anticipated to reach up to US$ 3,749.90 Mn by the end of the years 2027. The North America Smart Inhalers market is divided into the US, Canada, and Mexico.

The prevalence of COPD in the US has led to rising concern. COPD is recognized as the third leading cause of death by disease in the United States. More than 11 million people have been diagnosed with COPD, however a large number of population has been suffering from the condition even without being aware of the medical condition. COPD leads to serious long-term disability, eventually leading early death. At present, there is no cure hence the number of people dying from COPD is growing significantly during the recent years. As per data obtained by the CDC, among all the disorders, percent of visits to office-based physicians with COPD accounted for approximately 3.6% during 2016, whereas visits in emergency department accounted for 5.6%. In addition, the US has presence of various associations that provide help in the field of lung diseases. For instance, American Lung Association conducts research activities, education and training as well as undertakes initiatives to offer better treatment and support for the patients suffering with respiratory conditions such as asthma, COPD, influenza, lung cancer, pneumonia, and pulmonary fibrosis among others. The above mentioned factors are expected to significantly accelerate the growth of smart inhalers market in United States at the significant rate during the forecast period.

Key Player Analysis

The smart inhalers market majorly consists of the players such as GlaxoSmithKline plc; Adherium Limited; Novartis AG; Vectura Group plc; Cohero Health, Inc; Crux Product Design Ltd; Findair Sp. z o. o.; TEVA PHARMACEUTICAL INDUSTRIES LTD; 3M; and AMIKO DIGITAL HEALTH LIMITED. GlaxoSmithKline plc and Novartis AG are the top players in the smart inhalers market.

Novartis AG is a multinational group of companies, specialized in the research, development, manufacturing and marketing of a broad range of healthcare products, led by innovative pharmaceuticals including high-quality generic pharmaceuticals and eye care products. In the market of smart inhalers, the Novartis AG offers products such as, Ultibro Breezhaler, Seebri Breezhaler offered through the respiratory franchise of the pharmaceuticals business unit and Airflusal Forspiro, offered by Sandoz. Through the sales of Breezhalers, including products such as, Onbrez Breezhaler, Seebri Breezhaler and Ultibro Breezhaler, the company generated sales of around USD 703 million during 2018. The sales of Ultibro Breezhaler continued to record growth owing to positive results of the FLAME and CLAIM study, as well as the GOLD Strategy 2018 Report, which was further supported by the results of SUNSET study.

Recent Developments

Inorganic and organic strategies such as mergers and acquisitions are highly adopted by companies in the smart inhalers market. A few recent key market developments are listed below: 

  • In February 2022, Aptar Pharma announced the launch of HeroTracker Sense, a novel digital respiratory health solution that transforms a standard metered dose inhaler (pMDI) into a smart connected healthcare device. HeroTracker Sense is designed to help improve the world suffering from chronic respiratory diseases such as asthma, COPD, Cystic Fibrosis and other respiratory conditions caused by COVID-19, to track their MDI usage and facilitate improved adherence to their prescribed therapy.
  • In May 2020, AstraZeneca partnered with Propeller Health to add smart features to its Symbicort inhaler. With FDA clearance, smart inhaler developer Propeller Health connected platform to AstraZeneca’s Symbicort to help digitize the treatment of asthma and chronic obstructive pulmonary disease (COPD).
  • In July 2020, Teva Respiratory has launched the first digital rescue inhaler for patients aged 4 years and older and a companion app, according to the company. This rescue inhaler is equipped with Bluetooth wireless technology sensors, which connect with a companion mobile app.1 The patient will use an app to scan a QR code at the top of the inhaler, which will sync the inhaler to the app. It measures a breath actuation and shows how well the patient is using the inhaler.
  • In October 2021, BreatheSuite announced 510(k) clearance from the FDA for its Metered-Dose Inhaler V1 device, which turns existing inhalers into smart inhalers for people with asthma and COPD, according to a company press release.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product, Disorder, and End User

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

1. INTRODUCTION

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 market segmentation

1.3.1 Global Smart Inhalers Market – By Product

1.3.2 Global Smart Inhalers Market – By Disorder

1.3.3 Global Smart Inhalers Market – By End User

1.3.4 Global Smart Inhalers Market – By Geography

2. Global Smart inhalers Market – Key takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Global Smart inhalers market – market landscape

4.1 overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

4.2.2 Europe PEST Analysis

4.2.3 Asia Pacific PEST Analysis

4.2.4 Middle East & Africa PEST Analysis

4.2.5 South & Central America PEST Analysis

5. Global Smart inhalers market – Key INDUSTRY Dynamics

5.1 Key Market Drivers

5.1.1 Increasing Levels of Air Pollution as well as Rise in the Smoking Habits

5.1.2 Rising Prevalence of Asthma and COPD Across the Globe

5.1.3 Growing Geriatric Population

5.2 Key Market Restraints

5.2.1 Risks Associated with Cyber Threats

5.2.2 Limited Knowledge Regarding the Use of Smart Inhalers

5.3 Key Market OpportunitY

5.3.1 Growth in the Global Healthcare Market

5.4 Future Trend

5.4.1 Increasing Acceptance of Mobile Health Technology

5.5 Impact analysis

6. Smart inhalers market – Global Analysis

6.1 global Smart inhalers market Revenue Forecasts and Analysis

6.2 global Smart inhalers market, By Geography - Forecasts and Analysis

6.3 PERFORMANCE OF KEY PLAYERS

6.3.1 Novartis AG

6.3.2 GlaxoSmithKline plc.

7. global Smart inhalers Market analysis– by Product

7.1 overview

7.2 Global Smart inhalers Market, BY product 2018 & 2027 (%)

7.3 Inhalers market

7.3.1 Overview

7.3.2 Global Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

7.4 Nebulizers market

7.4.1 Overview

7.4.2 Global Nebulizers Market Revenue and Forecasts to 2027 (US$ Mn)

8. global Smart inhalers Market analysis– by Disorder

8.1 overview

8.2 Global Smart inhalers Market, BY Disorder 2018 & 2027 (%)

8.3 Asthma market

8.3.1 Overview

8.3.2 Global Asthma Market Revenue and Forecasts to 2027 (US$ Mn)

8.4 Chronic obstructive pulmonary disease market

8.4.1 Overview

8.4.2 Global Chronic Obstructive Pulmonary Disease Market Revenue and Forecasts to 2027 (US$ Mn)

9. global Smart inhalers Market analysis– by ENd User

9.1 overview

9.2 Global Smart inhalers Market, BY ENd User 2018 & 2027 (%)

9.3 HospitaLs & Clinics market

9.3.1 Overview

9.3.2 Global Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn)

9.4 Home Care Settings market

9.4.1 Overview

9.4.2 Global Home Care Settings Market Revenue and Forecasts to 2027 (US$ Mn)

10. Smart inhalers Market Revenue and Forecasts to 2027 – geographical analysis

10.1 North America Smart inhalers market Revenue and Forecasts to 2027

10.1.1 North America Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.2 North America Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.1.3 North America Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)

10.1.4 North America Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.1.5 North America Smart Inhalers Market Revenue And Forecasts to 2027, By Country (%)

10.1.6 US Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.6.1 US Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.6.2 US Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.1.6.3 US Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)

10.1.6.4 US Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.1.7 Canada Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.7.1 Canada Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.7.2 Canada Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.1.7.3 Canada Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)

10.1.7.4 Canada Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.1.8 Mexico Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.8.1 Mexico Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.8.2 Mexico Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.1.8.3 Mexico Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)

10.1.8.4 Mexico Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.2 Europe Smart inhalers market Revenue and Forecasts to 2027

10.2.1 Europe Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.2 Europe Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.2.3 Europe Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)

10.2.4 Europe Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.2.5 Europe Smart Inhalers Market Revenue And Forecasts to 2027, By Country (%)

10.2.6 UK Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.6.1 UK Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.6.2 UK Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.2.6.3 UK Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)

10.2.6.4 UK Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.2.7 Germany Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.7.1 Germany Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.7.2 Germany Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.2.7.3 Germany Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)

10.2.7.4 Germany Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.2.8 France Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.8.1 France Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.8.2 France Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.2.8.3 France Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)

10.2.8.4 France Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.2.9 Italy Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.9.1 Italy Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.9.2 Italy Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.2.9.3 Italy Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)

10.2.9.4 Italy Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.2.10 Spain Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.10.1 Spain Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.10.2 Spain Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.2.10.3 Spain Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)

10.2.10.4 Spain Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.3 Asia Pacific Smart inhalers Market Revenue and Forecasts to 2027

10.3.1 Asia Pacific Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.2 Asia Pacific Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.3.3 Asia Pacific Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)

10.3.4 Asia Pacific Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.3.5 Asia Pacific Smart Inhalers Market Revenue And Forecasts to 2027, By Country (%)

10.3.6 Japan Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.6.1 Japan Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.6.2 Japan Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.3.6.3 Japan Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)

10.3.6.4 Japan Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.3.7 China Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.7.1 China Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.7.2 China Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.3.7.3 China Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)

10.3.7.4 China Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.3.8 India Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.8.1 India Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.8.2 India Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.3.8.3 India Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)

10.3.8.4 India Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.3.9 South Korea Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.9.1 South Korea Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.9.2 South Korea Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.3.9.3 South Korea Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)

10.3.9.4 South Korea Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.3.10 Australia Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.10.1 Australia Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.10.2 Australia Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.3.10.3 Australia Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)

10.3.10.4 Australia Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.4 Middle East & Africa Smart inhalers Market Revenue and Forecasts to 2027

10.4.1 Middle East & Africa Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.2 Middle East & Africa Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.4.3 Middle East & Africa Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)

10.4.4 Middle East & Africa Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.4.5 Middle East & Africa Smart Inhalers Market Revenue And Forecasts to 2027, By Country (%)

10.4.6 UAE Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.6.1 UAE Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.6.2 UAE Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.4.6.3 UAE Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)

10.4.6.4 UAE Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.4.7 Saudi Arabia Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.7.1 Saudi Arabia Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.7.2 Saudi Arabia Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.4.7.3 Saudi Arabia Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)

10.4.7.4 Saudi Arabia Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.4.8 South Africa Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.8.1 South Africa Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.8.2 South Africa Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.4.8.3 South Africa Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)

10.4.8.4 South Africa Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.5 South and Central America Smart inhalers Market Revenue and Forecasts to 2027

10.5.1 South and Central America Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.2 South and Central America Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.5.3 South and Central America Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)

10.5.4 South and Central America Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.5.5 South and Central America Smart Inhalers Market Revenue And Forecasts to 2027, By Country (%)

10.5.6 Argentina Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.6.1 Argentina Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.6.2 Argentina Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.5.6.3 Argentina Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)

10.5.6.4 Argentina Smart inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.5.7 Brazil Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.7.1 Brazil Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.7.2 Brazil Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.5.7.3 Brazil Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)

10.5.7.4 Brazil Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11. Smart Inhalers Market– Industry Landscape

11.1 Overview

11.2 Comparative Company Analysis

11.3 Growth Strategies done by the companies in the Market, (%)

11.4 Organic Developments

11.4.1 Overview

11.5 Inorganic developments

11.5.1 Overview

12. Smart Inhalers Market–Key company profiles

12.1 GlaxoSmithKline plc.

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Financial Overview

12.1.4 Product Portfolio

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Adherium Limited

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Financial Overview

12.2.4 Product Portfolio

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Novartis AG

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Financial Overview

12.3.4 Product Portfolio

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Vectura Group plc

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Financial Overview

12.4.1 Product Portfolio

12.4.2 SWOT Analysis

12.4.3 Key Developments

12.5 Cohero Health, Inc.

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Financial Overview

12.5.4 Product Portfolio

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Crux Product Design Ltd

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Financial Information

12.6.4 Product Portfolio

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Findair Sp. z o. o.

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Financial Overview

12.7.4 Product Portfolio

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Teva Pharmaceutical Industries Ltd.

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Financial Overview

12.8.4 Product Portfolio

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 3M

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Financial Overview

12.9.4 Product Portfolio

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Amiko Digital Health Limited

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Financial Overview

12.10.4 Product Portfolio

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms


list of tables

TABLE 1. total number of persons aged 60 years or above by region, 2017 & 2050

TABLE 2. North America SMART INHALERS MARKET Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 3. North America SMART INHALERS MARKET Revenue And Forecasts to 2027, By disorder (US$ Mn)

TABLE 4. North America SMART INHALERS MARKET Revenue And Forecasts to 2027, By End User (US$ Mn)

TABLE 5. US SMART INHALERS MARKET Revenue And Forecasts to 2027, By product (US$ Mn)

TABLE 6. US SMART INHALERS MARKET Revenue And Forecasts to 2027, By disorder (US$ Mn)

TABLE 7. US SMART INHALERS MARKET Revenue And Forecasts to 2027, By End User (US$ Mn)

TABLE 8. Canada SMART INHALERS MARKET Revenue And Forecasts to 2027, By product (US$ Mn)

TABLE 9. Canada SMART INHALERS MARKET Revenue And Forecasts to 2027, By disorder (US$ Mn)

TABLE 10. Canada SMART INHALERS MARKET Revenue And Forecasts to 2027, By End User (US$ Mn)

TABLE 11. Mexico SMART INHALERS MARKET Revenue And Forecasts to 2027, By product (US$ Mn)

TABLE 12. Mexico SMART INHALERS MARKET Revenue And Forecasts to 2027, By disorder (US$ Mn)

TABLE 13. Mexico SMART INHALERS MARKET Revenue And Forecasts to 2027, By End User (US$ Mn)

TABLE 14. Europe SMART INHALERS MARKET Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 15. Europe SMART INHALERS MARKET Revenue And Forecasts to 2027, By disorder (US$ Mn)

TABLE 16. Europe SMART INHALERS MARKET Revenue And Forecasts to 2027, By End User (US$ Mn)

TABLE 17. UK SMART INHALERS MARKET Revenue And Forecasts to 2027, By product (US$ Mn)

TABLE 18. UK SMART INHALERS MARKET Revenue And Forecasts to 2027, By disorder (US$ Mn)

TABLE 19. UK SMART INHALERS MARKET Revenue And Forecasts to 2027, By End User (US$ Mn)

TABLE 20. Germany SMART INHALERS MARKET Revenue And Forecasts to 2027, By product (US$ Mn)

TABLE 21. Germany SMART INHALERS MARKET Revenue And Forecasts to 2027, By disorder (US$ Mn)

TABLE 22. Germany SMART INHALERS MARKET Revenue And Forecasts to 2027, By End User (US$ Mn)

TABLE 23. France SMART INHALERS MARKET Revenue And Forecasts to 2027, By product (US$ Mn)

TABLE 24. France SMART INHALERS MARKET Revenue And Forecasts to 2027, By disorder (US$ Mn)

TABLE 25. France SMART INHALERS MARKET Revenue And Forecasts to 2027, By End User (US$ Mn)

TABLE 26. Italy SMART INHALERS MARKET Revenue And Forecasts to 2027, By product (US$ Mn)

TABLE 27. Italy SMART INHALERS MARKET Revenue And Forecasts to 2027, By disorder (US$ Mn)

TABLE 28. Italy SMART INHALERS MARKET Revenue And Forecasts to 2027, By End User (US$ Mn)

TABLE 29. Spain SMART INHALERS MARKET Revenue And Forecasts to 2027, By product (US$ Mn)

TABLE 30. Spain SMART INHALERS MARKET Revenue And Forecasts to 2027, By disorder (US$ Mn)

TABLE 31. Spain SMART INHALERS MARKET Revenue And Forecasts to 2027, By End User (US$ Mn)

TABLE 32. Asia Pacific SMART INHALERS MARKET Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 33. Asia Pacific SMART INHALERS MARKET Revenue And Forecasts to 2027, By disorder (US$ Mn)

TABLE 34. Asia Pacific SMART INHALERS MARKET Revenue And Forecasts to 2027, By End User (US$ Mn)

TABLE 35. Japan SMART INHALERS MARKET Revenue And Forecasts to 2027, By product (US$ Mn)

TABLE 36. Japan SMART INHALERS MARKET Revenue And Forecasts to 2027, By disorder (US$ Mn)

TABLE 37. Japan SMART INHALERS MARKET Revenue And Forecasts to 2027, By End User (US$ Mn)

TABLE 38. China SMART INHALERS MARKET Revenue And Forecasts to 2027, By product (US$ Mn)

TABLE 39. China SMART INHALERS MARKET Revenue And Forecasts to 2027, By disorder (US$ Mn)

TABLE 40. China SMART INHALERS MARKET Revenue And Forecasts to 2027, By End User (US$ Mn)

TABLE 41. India SMART INHALERS MARKET Revenue And Forecasts to 2027, By product (US$ Mn)

TABLE 42. India SMART INHALERS MARKET Revenue And Forecasts to 2027, By disorder (US$ Mn)

TABLE 43. India SMART INHALERS MARKET Revenue And Forecasts to 2027, By End User (US$ Mn)

TABLE 44. South Korea SMART INHALERS MARKET Revenue And Forecasts to 2027, By product (US$ Mn)

TABLE 45. South Korea SMART INHALERS MARKET Revenue And Forecasts to 2027, By disorder (US$ Mn)

TABLE 46. South Korea SMART INHALERS MARKET Revenue And Forecasts to 2027, By End User (US$ Mn)

TABLE 47. Australia SMART INHALERS MARKET Revenue And Forecasts to 2027, By product (US$ Mn)

TABLE 48. Australia SMART INHALERS MARKET Revenue And Forecasts to 2027, By disorder (US$ Mn)

TABLE 49. Australia SMART INHALERS MARKET Revenue And Forecasts to 2027, By End User (US$ Mn)

TABLE 50. Middle East & Africa SMART INHALERS MARKET Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 51. Middle East & Africa SMART INHALERS MARKET Revenue And Forecasts to 2027, By disorder (US$ Mn)

TABLE 52. Middle East & Africa SMART INHALERS MARKET Revenue And Forecasts to 2027, By End User (US$ Mn)

TABLE 53. UAE SMART INHALERS MARKET Revenue And Forecasts to 2027, By product (US$ Mn)

TABLE 54. UAE SMART INHALERS MARKET Revenue And Forecasts to 2027, By disorder (US$ Mn)

TABLE 55. UAE SMART INHALERS MARKET Revenue And Forecasts to 2027, By End User (US$ Mn)

TABLE 56. Saudi Arabia SMART INHALERS MARKET Revenue And Forecasts to 2027, By product (US$ Mn)

TABLE 57. Saudi Arabia SMART INHALERS MARKET Revenue And Forecasts to 2027, By disorder (US$ Mn)

TABLE 58. Saudi Arabia SMART INHALERS MARKET Revenue And Forecasts to 2027, By End User (US$ Mn)

TABLE 59. South Africa SMART INHALERS MARKET Revenue And Forecasts to 2027, By product (US$ Mn)

TABLE 60. South Africa SMART INHALERS MARKET Revenue And Forecasts to 2027, By disorder (US$ Mn)

TABLE 61. South Africa SMART INHALERS MARKET Revenue And Forecasts to 2027, By End User (US$ Mn)

TABLE 62. South and Central America SMART INHALERS MARKET Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 63. South and Central America SMART INHALERS MARKET Revenue And Forecasts to 2027, By disorder (US$ Mn)

TABLE 64. South and Central America SMART INHALERS MARKET Revenue And Forecasts to 2027, By End User (US$ Mn)

TABLE 65. Argentina SMART INHALERS MARKET Revenue And Forecasts to 2027, By product (US$ Mn)

TABLE 66. Argentina SMART INHALERS MARKET Revenue And Forecasts to 2027, By disorder (US$ Mn)

TABLE 67. Argentina SMART INHALERS MARKET Revenue And Forecasts to 2027, By End User (US$ Mn)

TABLE 68. Brazil SMART INHALERS MARKET Revenue And Forecasts to 2027, By product (US$ Mn)

TABLE 69. Brazil SMART INHALERS MARKET Revenue And Forecasts to 2027, By disorder (US$ Mn)

TABLE 70. Brazil SMART INHALERS MARKET Revenue And Forecasts to 2027, By End User (US$ Mn)

TABLE 71. Organic Developments Done By Companies

TABLE 72. Inorganic developments done by Companies

TABLE 73. Glossary of Terms, Smart inhalers market


list of figures

FIGURE 1. Smart inhalers market Segmentation

FIGURE 2. Smart inhalers Segmentation, by region

FIGURE 3. Asia Pacific Smart inhalers market, Revenue (US$ Mn), By Geography 2018 & 2027

FIGURE 4. Global Smart inhalers Market By product, Market Share (%), 2018

FIGURE 5. Global Smart inhalers Market By Disorder, Market Share (%), 2018

FIGURE 6. Global Smart inhalers Market By END USER, Market Share (%), 2018

FIGURE 7. North America : PEST Analysis

FIGURE 8. Europe : PEST Analysis

FIGURE 9. Asia - Pacific : PEST Analysis

FIGURE 10. Middle East & Africa : PEST Analysis

FIGURE 11. South & Central America : PEST Analysis

FIGURE 12. GLOBAL smart inhalers market impact analysis of driver and restraints

FIGURE 13. global Smart inhalers market – Revenue Forecasts and Analysis – 2018- 2027

FIGURE 14. global Smart inhalers market – by geography Forecasts and Analysis – 2018- 2027

FIGURE 15. Prominent players in the Smart Inhalers Market

FIGURE 16. global Smart inhalers Market, by product 2018 & 2027 (%)

FIGURE 17. global inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 18. global Nebulizers Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 19. global Smart inhalers Market, by Disorder 2018 & 2027 (%)

FIGURE 20. global Asthma Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 21. global chronic obstructive pulmonary disease Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 22. global Smart inhalers Market, by ENd User 2018 & 2027 (%)

FIGURE 23. global Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 24. global home care settings Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 25. North America Smart inhalers Market REVENUE overview, by Country, 2018 (US$ MN)

FIGURE 26. North America SMART INHALERS MARKET Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 27. North America SMART INHALERS MARKET Revenue And Forecasts to 2027, By Country (%)

FIGURE 28. US SMART INHALERS MARKET Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 29. Canada SMART INHALERS MARKET Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 30. Mexico SMART INHALERS MARKET Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 31. Europe Smart inhalers Market REVENUE overview, by Country, 2018 (US$ MN)

FIGURE 32. Europe SMART INHALERS MARKET Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 33. Europe SMART INHALERS MARKET Revenue And Forecasts to 2027, By Country (%)

FIGURE 34. UK SMART INHALERS MARKET Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 35. Germany SMART INHALERS MARKET Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 36. France SMART INHALERS MARKET Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 37. Italy SMART INHALERS MARKET Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 38. Spain SMART INHALERS MARKET Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 39. Asia Pacific Smart inhalers Market REVENUE overview, by Country, 2018 (US$ MN)

FIGURE 40. Asia Pacific SMART INHALERS MARKET Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 41. Asia Pacific SMART INHALERS MARKET Revenue And Forecasts to 2027, By Country (%)

FIGURE 42. Japan SMART INHALERS MARKET Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 43. China SMART INHALERS MARKET Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 44. India SMART INHALERS MARKET Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 45. South Korea SMART INHALERS MARKET Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 46. Australia SMART INHALERS MARKET Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 47. Middle East & Africa Smart inhalers Market REVENUE overview, by Country, 2018 (US$ MN)

FIGURE 48. Middle East & Africa SMART INHALERS MARKET Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 49. Middle East & Africa SMART INHALERS MARKET Revenue And Forecasts to 2027, By Country (%)

FIGURE 50. UAE SMART INHALERS MARKET Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 51. Saudi Arabia SMART INHALERS MARKET Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 52. South Africa SMART INHALERS MARKET Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 53. South and Central America Smart inhalers Market REVENUE overview, by Country, 2018 (US$ MN)

FIGURE 54. South and Central America SMART INHALERS MARKET Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 55. South and Central America SMART INHALERS MARKET Revenue And Forecasts to 2027, By Country (%)

FIGURE 56. Argentina SMART INHALERS MARKET Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 57. Brazil SMART INHALERS MARKET Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 58. Comparative Company Analysis

FIGURE 59. Growth Strategies done by the companies in the Market, (%)

The List of Companies - Smart Inhalers Market

  1. GlaxoSmithKline plc
  2. Adherium Ltd.
  3. Vectura Group plc
  4. Novartis AG
  5. Findair Sp. z o. o.
  6. Cohero Health
  7. Crux Product Design Ltd
  8. Teva Pharmaceuticals
  9. 3M
  10. Amiko Digital Health Limited

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Smart Inhalers Market